A detailed history of Principal Securities, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Principal Securities, Inc. holds 40,442 shares of ABBV stock, worth $7.28 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
40,442
Previous 37,920 6.65%
Holding current value
$7.28 Million
Previous $6.5 Billion 22.79%
% of portfolio
0.19%
Previous 0.18%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$163.84 - $199.33 $413,204 - $502,710
2,522 Added 6.65%
40,442 $7.99 Billion
Q2 2024

Jul 31, 2024

BUY
$154.79 - $180.76 $741,289 - $865,659
4,789 Added 14.45%
37,920 $6.5 Billion
Q1 2024

May 10, 2024

BUY
$159.82 - $182.1 $199,455 - $227,260
1,248 Added 3.91%
33,131 $6.03 Billion
Q4 2023

Feb 07, 2024

BUY
$137.6 - $154.97 $4.39 Million - $4.94 Million
31,883 New
31,883 $4.94 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Principal Securities, Inc. Portfolio

Follow Principal Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Principal Securities, Inc. with notifications on news.